Compared with placebo, pharmacological treatment with cholinesterase inhibitors and memantine has shown improvements in outcomes such as cognition and global functioning in Alzheimer's disease [5,6]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.